Clínica Baviera, S.A. (BME:CBAV)
Spain · Delayed Price · Currency is EUR 54.80
-0.40 (-0.72%)
Oct 6, 2026, 5:35 PM CET
Clínica Baviera Market Cap
Clínica Baviera has a market cap or net worth of €878.62 million as of October 6, 2026. Its market cap has increased by 31.65% in one year.
Market Cap
878.62M
Enterprise Value
899.08M
Revenue
320.67M
Ranking
n/a
PE Ratio
19.09
Stock Price
€54.80
ChartMarket Cap Chart
Since April 10, 2007, Clínica Baviera's market cap has increased from 369.53M to 878.62M, an increase of 137.77%. That is a compound annual growth rate of 4.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 878.62M | 10.41% |
| Dec 31, 2025 | 795.80M | 59.55% |
| Dec 31, 2024 | 498.78M | 33.02% |
| Dec 29, 2023 | 374.97M | 31.81% |
| Dec 30, 2022 | 284.48M | -17.68% |
| Dec 30, 2021 | 345.60M | 50.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.72B |
| Laboratorios Farmaceuticos Rovi | 2.94B |
| Almirall | 2.23B |
| Faes Farma | 1.41B |
| Pharma Mar | 1.24B |
| Oryzon Genomics | 223.92M |
| Laboratorio Reig Jofre | 215.04M |
| Prim, S.A. | 214.30M |